Viewing Study NCT00658593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:15 AM
Ignite Modification Date: 2026-02-26 @ 12:20 AM
Study NCT ID: NCT00658593
Status: TERMINATED
Last Update Posted: 2023-08-04
First Post: 2008-04-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Sponsor: NCIC Clinical Trials Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extrahepatic Bile Duct Cancer View
None Gallbladder Cancer View
None Liver Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the extrahepatic bile duct View
None unresectable extrahepatic bile duct cancer View
None recurrent extrahepatic bile duct cancer View
None adenocarcinoma of the gallbladder View
None adenocarcinoma with squamous metaplasia of the gallbladder View
None unresectable gallbladder cancer View
None recurrent gallbladder cancer View
None liver and intrahepatic biliary tract cancer View